BIOLAND, Ltd
Records under this name other than patents BIOLAND, Ltd holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 10 of 10 · Back to BIOLAND, Ltd
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,426,383 | Anti-aging composition for external use comprising low and high molecular weight hyaluronic acids and the polysaccharides extracted from root bark of Ulmus davidiana Formerly held In force · USPTO record | In force | USPTO record | |
| US 8,604,087 | Composition for treating or preventing amyloid-related diseases comprising 4-O-methylhonokiol Formerly held In force · USPTO record | In force | USPTO record | |
| US 7,932,232 | Cosmetic Composition Comprising Beta-Fructosyl-L-Ascorbic Acid for Skin Whitening Formerly held Lapsed on the fee record Ended Apr 26, 2023 · High confidence | Lapsed on the fee record | Ended Apr 26, 2023 | High confidence |
| US 6,933,403 | Mono Carbonylation of Benzene Diols Formerly held Term ended Term ended Oct 14, 2022 · High confidence | Term ended | Term ended Oct 14, 2022 | High confidence |
| US 6,388,103 | Preparation Method of Arbutin Intermediates Formerly held Term ended Term ended Apr 20, 2021 · High confidence | Term ended | Term ended Apr 20, 2021 | High confidence |
| US 6,018,095 | Method for preparing an implantable composite material, resulting material, implant including said material, and kit therefor Term ended Term ended Jan 22, 2018 · USPTO record | Term ended | Term ended Jan 22, 2018 | USPTO record |
| US 6,217,614 | Process for treating bone tissue and corresponding implantable biomaterials Formerly held Term ended Term ended Jan 16, 2018 · USPTO record | Term ended | Term ended Jan 16, 2018 | USPTO record |
| US 6,120,558 | Method for manufacturing and treating textiles Formerly held Lapsed on the fee record Ended Sep 19, 2008 · USPTO record | Lapsed on the fee record | Ended Sep 19, 2008 | USPTO record |
| US 5,723,012 | Uses for a current of supercritical carbon dioxide as an antiviral agent Formerly held Term ended Term ended no later than Mar 3, 2018 · Low confidence | Term ended | Term ended no later than Mar 3, 2018 | Low confidence |
| US 5,725,579 | Process for treating bone tissue and corresponding implantable biomaterials Formerly held Term ended Term ended no later than Mar 10, 2018 · Low confidence | Term ended | Term ended no later than Mar 10, 2018 | Low confidence |